Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
This document describes a post-approval registry for Exablate 4000 Type 1.0/1.1 unilateral thalamotomy, evaluating its use for tremor in tre…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: LFP-based Parameter Prediction in DBS for Parkinson's Disease
This clinical trial update describes a study investigating local field potential-based parameter prediction in deep brain stimulation for Pa…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease [NA]
Clinical trial update on ExAblate Pallidotomy for medically refractory dyskinesia or motor fluctuations in advanced Parkinson disease; the s…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers [NA]
A clinical trial to test dyadic mindfulness for people with Parkinson's disease and their caregivers. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease [Phase 1]
Phase 1 study to evaluate the safety of VT-5006 in healthy volunteers and individuals with Parkinson's disease is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis
This update describes a global individual participant data meta-analysis examining the impact of nut consumption on prevention of non-commun…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
A post-approval registry study evaluating Exablate 4000 Type 1.0/1.1 unilateral pallidotomy for advanced idiopathic Parkinson's disease with…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Effects Of Strategy Training And PNF On Balance, Gait, And Independence In Parkinson's Disease [NA]
A clinical trial evaluating the effects of strategy training and proprioceptive neuromuscular facilitation (PNF) on balance, gait, and indep…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Effectiveness of Online Program and Task-related Training for Parkinson's Disease [NA]
A clinical trial at Chang Gung University is evaluating an online program and task-related training for Parkinson disease and is currently r…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease [Phase 4]
The document announces a Phase 4 clinical trial (RELIEF-PD) evaluating crisugabalin for nociplastic pain in Parkinson's disease, with status…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease [NA]
A University of Minnesota-sponsored clinical trial on vestibular and cortical contributions to transitions in freezing of gait in Parkinson …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Dual-Task Balance and Gait Training Combined With Cognitive Training in Parkinson's Patients [NA]
This clinical trial update describes a Parkinson's disease study evaluating dual-task balance and gait training combined with cognitive trai…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Turkish Validation of the Parkinson Disease Cognitive Functional Rating Scale
A Turkish validation study is enrolling by invitation to assess the reliability and validity of the Turkish version of the Parkinson Disease…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Cerebellar Stimulation and Cognitive Control [NA]
A clinical trial update notes that a cerebellar stimulation study assessing cognitive control is currently recruiting, with conditions inclu…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease [Phase 2]
Phase 2 clinical trial assessing safety, tolerability and symptomatic efficacy of the ROCK inhibitor fasudil in patients with Parkinson's di…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices [NA]
This clinical trial update describes an ongoing study by Azienda Ospedaliera di Perugia aiming to profile Parkinson's disease molecularly us…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Digitally-enhanced, Decentralized, Multi-omics Observational Cohort
An observational cohort study that uses digital, decentralized, multi-omics approaches, sponsored by Greece 2021 Committee, is currently enr…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Everyday Memory Impairment in PD-related Cognitive Decline [NA]
A clinical trial update describes an active-not-recruiting study investigating everyday memory impairment in Parkinson disease-related cogni…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Multicontext Approach for Cognitive Function in Parkinson Disease [NA]
This document notes a clinical trial investigating a multicontext approach to cognitive function in Parkinson disease, with status not yet r…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Intracranial Recordings to Characterize Action Regulation Mechanisms [NA]
This clinical trial update describes intracranial recordings to characterize action regulation mechanisms in Parkinson disease; enrollment i…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinson's Disease [NA]
A completed clinical trial evaluating a multicomponent exercise protocol with emphasis on muscle power training for bradykinesia in Parkinso…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core
The update notes an enrolling-by-invitation clinical trial evaluating circuit-based deep brain stimulation for Parkinson's disease, run by t…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Terazosin And Metabolic Energetics in Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating terazosin's effects on metabolic energetics in Parkinson's disease; status: not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging [NA]
A university-led trial is investigating how alpha-synuclein spreads in Parkinson's disease using blood biomarkers and neuroimaging, with rec…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease [NA]
A clinical trial evaluating the cost-effectiveness of Cue2Walk, an automated freezing-detection and external-cue system, versus usual care i…